Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 305-748-4 | CAS number: 95009-22-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
Skin irritation:
There is no information on the non-human skin irritation potential of cocoa powder itself, but there isin vivo,ex vivo, andin vitrodata that demonstrates a protective effect of cocoa powder extracts on skin cells (see below). There is also information on the skin irritation potential of cocoa powder from human skin sensitization/provocation studies (see section 5.3.1.2).
Human Information:
Mucous membranes are generally more sensitive to irritants. Human oral uptake of chocolate, which can be defined as cocoa powder that has not or has been partially depleted from cocoa butter, is tolerated by the mucous membranes of the mouth and gut without any signs of irritation. The same holds true for chocolate drinks, i.e., cocoa powder suspended/dissolved in water.
Full cocoa powder or parts of it are actually components of several skin care products, including face masks (http://www.cosmeticsdesign-europe.com/content/search?SearchText=cocoa; last visit Sep. 2012). Indeed, cocoa butter is “widely used as an active excipient in skin care products” (Gasser et al. 2008).
Despite the handling of cocoa powder in industrial settings over more than 200 years, there are no recorded reports of skin irritation in workers at these sites.
A search of PubMed with cocoa and (irritant or irritancy and skin) in title or abstract gives no publication on its irritative action. (http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed; last search Jan., 2013).
Cocoa powder and chocolate have both been used in several human skin sensitization studies using skin prick and dermal patch testing methods in potentially highly sensitized individuals (for example: long-term confectionery workers employed in dusty areas, children with known allergic contact dermatitis, and in patients with a history of immediate adverse reaction following food ingestion). Although in each study, some individuals demonstrated a typical sensitization response to skin challenge with chocolate and/or cocoa powder, there was no identified effect on the skin of the majority of individuals in each study following direct provocation.
Eye irritation:
In assays with two cocoa powder samples (assayed to be at extremes of lipid content found in commercial cocoa powders) the Bovine Corneal Opacity and Permeability (BCOP) tests were negative for corrosion and severe irritation to the eye as expected. It is believed that cocoa would cause irritation if any by a mechanical process due to its physical form as a dust and not via any chemical action of its constituents. This is based on a long history of human exposure to cocoa powder by workers and consumers.
Justification for classification or non-classification
The following information is taken into account for any hazard / risk assessment.
Skin irritation: The lack of any irritative effects of cocoa powder extracts inin vivoandex vivosystems, along with a lack of effects after oral uptake in rats and in humans, and no effects after skin contact in workers and consumers are considered to be sufficient to indicate no irritation of cocoa powder to the skin.
Eye irritation: The lack of positive ex-vivo findings in the BCOP assay and a lack of mucosal irritation/corrosion, or any treatment related ophthalmoscopy findings in a 104 week dietary rat carcinogenicity study, along with a lack of reported eye related damage in cocoa manufacturers and consumers of cocoa are considered to be sufficient to indicate no irritation of cocoa powder to the eye.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
